Literature DB >> 6224609

Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.

V Barnaba, A Musca, C Cordova, M Levrero, G Ruocco, V Albertini-Petroni, F Balsano.   

Abstract

The relationship between T cell subset, as defined by monoclonal antibodies, and suppressor cell function, using a short lived suppressor cell assay, was studied in 38 chronic hepatitis B virus (HBV) carriers and in 32 patients with HBsAg negative chronic active hepatitis (CAH). Patients with HBV chronic infection showed an absolute reduction in the OKT4 positive subset and a significantly decreased OKT4/OKT8 ratio, as compared with healthy controls. Patients with anti-nuclear antibodies (ANA) and anti-smooth muscle antibodies (ASMA) positive CAH with or without antibodies to HBV antigens, namely anti-HBs and anti-HBc, demonstrated a significant reduction in cytotoxic/suppressor T cells and an increased helper/suppressor ratio. A negative correlation between suppressor index (SI) and OKT4/OKT8 ratio (P less than 0.01), and a positive correlation between SI and OKT8 positive cells absolute number (P less than 0.01) were also observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224609      PMCID: PMC1535673     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Cytoplasmic localisation of Australia antigen in the liver.

Authors:  S Hadziyannis; A Moussouros; C Vissoulis; A Afroudakis
Journal:  Lancet       Date:  1972-05-06       Impact factor: 79.321

2.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.

Authors:  A Alberti; G Realdi; F Bortolotti; A M Rigoli
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  Suppressor cell activity in viral and non-viral chronic active hepatitis.

Authors:  F Tremolada; G Fattovich; G Panebianco; G Ongaro; G Realdi
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

5.  Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.

Authors:  C de Galocsy; P J Jenkins; G Mieli-Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

6.  Suppressor cells assayed by three different methods in patients with chronic active hepatitis and systemic lupus erythematosus.

Authors:  H M Coovadia; I R MacKay; A J d'Apice
Journal:  Clin Immunol Immunopathol       Date:  1981-02

7.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Abnormalities of immunoregulatory T cells in disorders of immune function.

Authors:  E L Reinherz; A Rubinstein; R S Geha; A J Strelkauskas; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-11-08       Impact factor: 91.245

9.  Immunoregulatory T-cell function in acute and chronic liver disease.

Authors:  S Kakumu; K Yata; T Kashio
Journal:  Gastroenterology       Date:  1980-10       Impact factor: 22.682

10.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

Authors:  F V Chisari; K L Castle; C Xavier; D S Anderson
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

View more
  9 in total

1.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

2.  The relationship between T cell subsets and T suppressor cell function in hepatitis B.

Authors:  F Liu; P H Song; L J Hao
Journal:  J Tongji Med Univ       Date:  1987

3.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

4.  Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.

Authors:  L G Filion; R Saginur; N Szczerbak
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection.

Authors:  R E Solomon; M VanRaden; R A Kaslow; D Lyter; B Visscher; H Farzadegan; J Phair
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

6.  Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis.

Authors:  D A Vuitton; S Bresson-Hadni; L Laroche; D Kaiserlian; S Guerret-Stocker; J L Bresson; M Gillet
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

7.  Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitis.

Authors:  V Barnaba; E Tamburrini; V Laghi; R Cauda; M Levrero; G Ruocco; L Ortona; F Balsano
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

8.  Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells.

Authors:  W N Bartholomaeus; W D Reed; R A Joske
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b.

Authors:  E H Im; B S Lee; J K Sung; S O Lee; K T Lee; S M Lee; S H Kim; K S Seo; J H Kim; S G Kim; N J Kim; H Y Lee
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.